Pancreatitis Severity and Gut Bacteria Study
Part of Digestive system clinical trials.
This study looks at how the bacteria in your gut (microbiome) might affect the severity of a first-time acute pancreatitis attack. It aims to see if certain gut bacteria can predict how serious the illness will be, which could help doctors treat patients better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with acute pancreatitis for the first time in the last 2 days.
- You are 18 years old or older.
- You can understand and sign a consent form.
- You have not had more than 2 attacks of pancreatitis before.
- You do not have signs of long-term (chronic) pancreatitis.
- You are not being transferred from another hospital after being there for more than 2 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how gut bacteria change during acute pancreatitis and whether analyzing them can help predict how severe the condition will become. It may lead to better treatments and faster recovery.
This trial tests whether taking a probiotic called Bifidobacterium longum can help people with acute pancreatitis recover better. The study compares the probiotic against a placebo (a pill with no active ingredient) to see if it reduces inflammation and complications.
This study looks at why some people develop diabetes after acute pancreatitis and how that process works in the body. It may help doctors better predict risk and tailor care for people recovering from pancreatitis.
This study looks at specific blood markers during an acute pancreatitis episode to better understand the condition. It may help improve treatment for future patients.
This study follows adults who have acute pancreatitis (sudden inflammation of the pancreas) to learn more about how it affects them and what happens over time. It aims to improve care by understanding common symptoms and outcomes.
This trial studies how “inflammation” in the pancreas changes over time—going from a first or repeated attack to long-term (chronic) pancreatitis. It may help doctors understand what drives progression and identify people at higher risk for chronic disease.
Hear when a new Acute Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.